Moderna, Inc. and the nonprofit scientific research organization IAVI, on April 7th, announced a new collaboration to employ mRNA technology to meet the challenge...
KeyPlants, a leading provider of innovative life science facilities and PODs, announced that it has shipped a first-of-its-kind vaccine manufacturing filling facility to Senegal...
Moderna, Inc., on Wednesday announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing...
BioNTech announced the expansion of its strategic collaboration with Regeneron to advance the Company’s FixVac candidate BNT116 in combination with Libtayo® (cemiplimab), a PD-1...
Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025
Moderna...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced that it has established...